RN

Rishab Nithyanand

Director Director DIN 03497182
DIN 03497182 First appointment Apr 2011 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2011
Shareholding value Locked Premium profile

About Rishab Nithyanand

Rishab Nithyanand has 15 years in corporate governance. Formerly with 1 company, such as Fg Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03497182
Primary Designation Director
First Appointment 23 Apr 2011
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Fg Pharma Private Limited U33100TN2011PTC080270
Director 23 Apr 2011 2011 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fg Pharma Private Limited
Premium access

Shareholding and investment profile for Rishab Nithyanand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rishab Nithyanand

Rishab Nithyanand has 15 years in corporate governance. Formerly with 1 company, such as Fg Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Rishab Nithyanand is associated with 0 companies as a director.

Rishab Nithyanand has expertise in General Business.

Rishab Nithyanand has 15 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available